Drug Shortage Report for HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML
| Report ID | 102486 |
| Drug Identification Number | 01935941 |
| Brand name | HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML |
| Common or Proper name | Heparin Sodium |
| Company Name | B. BRAUN MEDICAL INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CITRIC ACID DEXTROSE SODIUM PHOSPHATE DIBASIC HEPARIN SODIUM |
| Strength(s) | 93MG 5G 410MG 5000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 500mL |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-12-05 |
| Estimated end date | 2020-02-28 |
| Actual end date | 2020-02-06 |
| Shortage status | Resolved |
| Updated date | 2020-02-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 824 TWELFTH AVENUE BETHLEHEM, PENNSYLVANIA UNITED STATES 18018 |
| Company contact information | Cindy Katsempris; cindy.katsempris@bbraunusa.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-02-07 | English | Compare |
| v6 | 2020-02-05 | French | Compare |
| v5 | 2020-02-05 | English | Compare |
| v4 | 2020-01-07 | French | Compare |
| v3 | 2020-01-07 | English | Compare |
| v2 | 2020-01-07 | French | Compare |
| v1 | 2020-01-07 | English | Compare |
Showing 1 to 7 of 7